Advertisement

Teleflex Incorporated TFX

Set alert

Price alert · TFX

All alert types
140.67 USD +0.90 +0.64%

At close · Nov 2

140.67 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
140.38 × 100
Ask
140.74 × 500
138.33 Day range 141.58
100.18 52-week range 145.00
YTD
+15.27%
1 year
+13.02%
Open
140.25
Prev close
139.77
Mkt cap
5.96B
Vol
923.08K
Avg vol
724.46K
EPS
-8.48
P/E
0.00
Div yield
0.97%
More statistics
Low
138.33
High
141.58
Forward P/E
12.85
Beta
0.83
Short ratio
4.99
Inst. own
116.12%
Dividend
1.36
Ex-div date
Aug 13, 2026
Earnings
Nov 5, 2026
50-d avg
131.34
200-d avg
125.16
1y target
154.00

1M chart

Chart tools
Interval

Events in this range
  • Oct 14, 2026Rating: Truist Securities · Hold → Hold
Signals (10)
NameDateAgo
RSI: OverboughtOct 29, 20264 days ago
RSI: OverboughtOct 27, 20266 days ago
SMA: BullishOct 22, 20261 week ago
SMA: BearishOct 21, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BullishOct 15, 20262 weeks ago
SMA: BearishOct 13, 20262 weeks ago
SMA: BullishOct 12, 20263 weeks ago
SMA: BearishOct 7, 20263 weeks ago
SMA: BullishOct 5, 20264 weeks ago

Key statistics

Market cap
5.96B
Enterprise value
8.54B
Trailing P/E
0.00
Forward P/E
12.85
PEG ratio
0.16
Price / sales
2.64
Price / book
2.05
EPS (TTM)
-8.48
Beta
0.83
Dividend yield
0.97%
Payout ratio
103.82%
Profit margin
-45.76%
Revenue (TTM)
2.25B
Revenue growth
28.90%
Free cash flow
179.54M
Total cash
323.94M
Total debt
2.94B
Return on equity
-0.70%
Shares outstanding
42.37M
Short % of float
15.61%
50-day average
131.34
200-day average
125.16

Analyst view

Consensus: buy

Buy
Price target (mean) 154.00 +9.5% upside
Target (low)
138.00
Target (mean)
154.00
Target (high)
170.00
Ratings (0m) 12 6 buy · 6 hold · 0 sell
  • Strong buy4
  • Buy2
  • Hold6
  • Sell0
  • Strong sell0

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate 1.89.

Earnings history

Financials — quick view

All financials
TFX Revenue — quarterly 570.33M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
TFX Net income — quarterly 99.69M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
TFX EPS — quarterly 2.29
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

TFX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 20261.90———
Aug 6, 2026Jun 30, 20261.281.76+0.48+37.50%
May 7, 2026Mar 31, 20261.211.39+0.18+14.88%
Feb 26, 2026Dec 31, 20253.731.93-1.80-48.26%
Nov 6, 2025Sep 28, 20253.383.67+0.29+8.58%
Jul 31, 2025Jun 29, 20253.363.73+0.37+11.01%

Upgrades / downgrades

TFX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 14, 2026Truist SecuritiesmainHoldHold
Sep 28, 2026B of A SecuritiesupNeutralBuy
Aug 25, 2026NeedhammainBuyBuy
Aug 11, 2026UBSmainNeutralNeutral
Aug 10, 2026Truist SecuritiesmainHoldHold
Aug 7, 2026Piper SandlerreitOverweightOverweight

About Teleflex Incorporated

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
teleflex.com

News

Your note

Sign in to keep a note on TFX — it syncs with the Stock Master app.

Institution ownership

TFX institution ownership
Holder% heldSharesValueReported
Blackrock Inc.12.82%5,431,818763.74MJun 29, 2026
Jupiter Topco LLC10.25%4,342,512610.58MJun 29, 2026
T. Rowe Price Investment Management, Inc.7.54%3,194,710449.19MJun 29, 2026
Vanguard Portfolio Management LLC5.70%2,416,998339.84MJun 29, 2026
Vanguard Capital Management LLC4.71%1,995,717280.61MJun 29, 2026
Sessa Capital IM, L.P.3.60%1,526,228214.60MJun 29, 2026

Fund ownership

TFX fund ownership
Holder% heldSharesValueReported
JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund6.81%2,885,870405.77MJun 29, 2026
iShares Trust-iShares Core S&P Small-Cap ETF5.96%2,523,757354.85MSep 29, 2026
T. Rowe Price Mid-Cap Growth Fund, Inc.3.88%1,646,114231.45MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.31%1,404,145197.43MJun 29, 2026
UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd.2.53%1,073,930151.00MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.40%1,015,718142.82MJun 29, 2026
Advertisement